Table 6.
Fixed effects parameters estimates of the predictors of willingness to receive COVID-19 vaccines, February 2021 (n = 6639).
| 95% Confidence Intervale | |||||||
|---|---|---|---|---|---|---|---|
| Predictor | Estimate | SE | Lower | Upper | df | t | Sig. |
| (Intercept) | 3.809 | 0.073 | 3.666 | 3.951 | 2.96 | 52.3 | <0.001 |
| Pharmaceutical Industry | 0.304 | 0.018 | 0.269 | 0.340 | 6633.72 | 16.8 | <0.001 |
| Natural Immunity | −0.270 | 0.016 | −0.301 | −0.239 | 6604.25 | −17.1 | <0.001 |
| Risk/Benefit Ratio | 0.285 | 0.019 | 0.248 | 0.322 | 6633.77 | 15.2 | <0.001 |
| Novel Vaccines | 0.382 | 0.018 | 0.347 | 0.417 | 6633.99 | 21.5 | <0.001 |
Multi-level linear regression analysis was carried out with a significance level (Sig.) < 0.05.